We serve Chemical Name:Chloroacetyl isocyanate CAS:4461-30-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Chloroacetyl isocyanate
CAS.NO:4461-30-7
Synonyms:2-chloroacetyl isocyanate;EINECS 224-715-4;MFCD00002034
Molecular Formula:C3H2ClNO2
Molecular Weight:119.50600
HS Code:2929109000
Physical and Chemical Properties:
Melting point:25°C
Boiling point:50-55ºC (20 mmHg)
Density:1.403
Index of Refraction:1.463
PSA:46.50000
Exact Mass:118.97700
LogP:0.08760
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3080
Packing Group:III
Contact us for information like 2-chloroacetyl isocyanate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00002034 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-chloroacetyl isocyanate Use and application,2-chloroacetyl isocyanate technical grade,usp/ep/jp grade.
Related News: Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. pd 142893 manufacturers Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. pTH (44-68) (human) suppliers The European Medicines Agency on Friday rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant (istradefylline), which the US FDA approved in 2019 under the brand name Nourianz. 3-bromo-5-(2-chloropyridin-4-yl)pyridine vendor & factory The $672 million raised in the listing will go toward expanding Stevanato’s factories in Italy and China and building a new plant for vials, syringes and cartridges in Fishers, Indiana—sweetened by $2.9 million in conditional tax credits from the state—that’s expected to bring more than 200 jobs to the area.,In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks.
